Inflammatory bowel disease (IBD) is a type of chronic recurrent inflammation disease that
mainly includes Crohn's disease and ulcerative colitis. Currently, the treatments for IBD …

In the struggle against diseases, the development of nano-therapy has certainly been a
tremendous progression owing to the various superiority, and chitosan is no doubt a kind of …

Ulcerative colitis is a chronic condition in which a dysregulated immune response
contributes to the acute intestinal inflammation of the colon. Current clinical therapies often …

While mesalamine, a 5-aminosalicylic acid (5-ASA), is pivotal in the management of
inflammatory bowel disease (IBD) through both step-up and top-down approaches in clinical …

Rationale: The therapeutic benefits of bilirubin in the treatment of ulcerative colitis (UC) are
considerable, whereas the underlying mechanism of bilirubin on UC remains unclear …

Dopamine is a well-known neurotransmitter due to its involvement in Parkinson's disease
(PD). Dopamine is not only involved in PD but also controls multiple mental and physical …

Mounting evidence underscores the pivotal role of the intestinal barrier and its convoluted
network with diet and intestinal microbiome in the pathogenesis of inflammatory bowel …

Excessive reactive oxygen species (ROS) is a hallmark of both the onset and progression of
inflammatory bowel disease (IBD), where a continuous cycle of ROS and inflammation …

Hepatology Publish Ahead of Print DOI:10.1097/HEP.0000000000000985 Page 1 Intestinal
IL-33 promotes microbiota-derived trimethylamine N-oxide synthesis and drives metabolic …

This study aimed to investigate the alleviative effects of fucosylated chondroitin sulfate from
sea cucumber Stichopus chloronotus (fCSsingle bond Sc) on the intestinal barrier injury and …